论文部分内容阅读
AIM To evaluates the effectiveness and safety of thefirst generation, NS3/4A protease inhibitors (PIs) inclinical practice against chronic C virus, especially inpatients with advanced fibrosis.METHODS: Prospective study and non-experimentalanalysis of a m